𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Commentary. Is infliximab effective for induction of remission in patients with ulcerative colitis?

✍ Scribed by Dr. Gary R. Lichtenstein

Book ID
110085934
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
88 KB
Volume
7
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors of early response to inflixim
Predictors of early response to infliximab in patients with ulcerative colitis
✍ Marc Ferrante; SΓ©verine Vermeire; Konstantinos H. Katsanos; Maja Noman; Gert Van πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 1 views

## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w

Direct comparison of two different mesal
Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
✍ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Hidetaka Sasaki; Toy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

Background: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. ## Methods: In a multicenter, double-blind, randomized study, 229 patients wit